Columnist Caroline Gainer experiences relentless fatigue, chills, and sweating, possibly from COPD and/or chronic ...

On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...

Posters support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD populationLONDON and ...

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca, in collaboration with Amgen, is ...

Patients with COPD are at increased risk for infections, making avoidance and effective treatments key in management.

No decline in lung function observed at 6-week interim analysis builds upon positive safety and biomarker data Phase 2a study ...

Content by Health System. With Asthma Peak Week typically during the middle of September, now is a great time to learn the ...

The likelihood for mortality during hospitalization was increased among those with COPD or asthma vs. asthma-COPD overlap ...

Background Balloon pulmonary angioplasty (BPA) improves haemodynamics in patients with inoperable chronic thromboembolic ...

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca has launched a Phase II clinical study titled ‘A Phase II, ...